NeuroSense Therapeutics (NASDAQ: NRSN) grants GM Hagit Binder 200,000 shares

NodeGuardian · 2026-04-01T10:20:56+00:00

NeuroSense Therapeutics awarded General Manager Hagit Binder 200,000 Ordinary Shares as compensation, vesting over two years. After this grant, she holds a total of 521,806 shares.

NodeGuardian

2026-04-01 10:20:56

Abstract generation in progress

NeuroSense Therapeutics (NASDAQ: NRSN) has granted its General Manager, Hagit Binder, 200,000 Ordinary Shares as a share-based compensation award. These restricted shares, which vest in equal quarterly installments over two years starting March 26, 2026, are part of the company’s 2018 Share Incentive Plan. Following this grant, Binder directly holds 521,806 Ordinary Shares.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.